
Jan 13 (Reuters) - IDEXX Laboratories IDXX.O on Tuesday named insider Michael Erickson as its next chief executive officer and said incumbent Jonathan Mazelsky will retire in 2027.
The appointment will be effective May 12, at which time Mazelsky will transition to the role of executive chair, the company said.
Erickson joined IDEXX in 2011 and has since held several senior roles across the company. He currently serves as Executive Vice President and General Manager at IDEXX's Global Point of Care Diagnostics and Telemedicine lines of business.
Mazelsky will retire from the company immediately after the annual shareholders meeting in May 2027, IDEXX added.
The Westbrook, Maine-based company sells blood and urine analyzers, imaging systems and practice software, along with running reference laboratories for complex tests.